Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients

Larry Beresford  |  Issue: December 2017  |  December 17, 2017

“Rheumatologic diseases come with emotional fallout. They can change the course of a person’s life and adversely affect their sense of self. We can add to that neurobiological factors, with new evidence suggesting depression itself may be a type of inflammatory disease,” she says.

Dr. Evers

Dr. Evers

Not all rheumatology patients have depression, notes Andrea Evers, PhD, professor of health psychology and chair of the Health, Medical and Neuropsychology Unit at Leiden University in The Netherlands. “A majority of our patients can handle a condition like rheumatoid arthritis in their lives with their existing coping resources. But rheumatologists struggle with a subgroup of patients who are prone to depression,” she says. “Sometimes, the mental health issue is independent of the disease. But we know people with high levels of rheumatic disease are already experiencing stress, which in turn has a close relationship with rheumatologic disease.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What Does the Research Tell Us?

Research has demonstrated prevalence of depression and anxiety in such conditions as rheumatoid arthritis at double the rates in the general population, and milder levels of psychological distress are even more common.1 Studies report ranges of depression from 5–20% in patients with RA.2

Symptoms of depression and anxiety are also associated with poorer health outcomes, increased disability and reduced treatment response, and with worse health-related quality of life.3,4 But only a fraction of those with depression and anxiety receive treatment for those symptoms.5

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Fatigue in RA is also associated with psychological correlates, especially poor mood.6 There is a relationship between stress and exacerbation of RA, and between resilience factors and RA management.7 Researchers have also documented the impact of psychological factors on patients’ responses to RA treatment.8

Loneliness has been shown to have an impact on patients’ daily pain in fibromyalgia, and loneliness and lack of social support are possible risk factors for worse physical and psychological functioning in a variety of somatic conditions, including RA and fibromyalgia.9,10 Rheumatology research has even identified connections with premature mortality. One recent study suggests treatment with antidepressants can lead to RA remission, and others have asked if it is possible to accurately identify a fibromyalgia or RA personality.11-13

A lot of people are trying to figure out cause and effect, says Faith Matcham, PhD, CPsychol, a post-doctoral research associate at the Institute of Psychiatry, Psychology and Neuroscience at Kings College, London, England. “I don’t think that’s the most important question, but rather how do these two things relate to each other? If you have one, how does it interact with the other?” she explains.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsPain SyndromesPractice Support Tagged with:anxiety disordersbehaviorcognitivecomorbiditiesDepressionfatigueFibromyalgiaLupusManagementMental Healthpatient carepsychologicalquality of lifeRARheumatoid arthritisrheumatologic conditionsrheumatologistrheumatologySLEtherapyTreatment

Related Articles

    7 Tools to Identify Depression

    August 1, 2014

    Why screening for depressive symptoms in patients with arthritis is needed

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

    Depression & Anxiety Linked to Poor Rheumatoid Arthritis Outcomes

    September 18, 2015

    NEW YORK (Reuters Health)—Rheumatoid arthritis patients with depression and anxiety symptoms may have worse outcomes and poorer response to prednisolone, a secondary analysis of the CARDERA trial has found. “The strength of association between depression/anxiety and disease activity outcomes and treatment response warrants routine screening,” the study’s lead author Faith Matcham at King’s College London…

    Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health

    June 14, 2018

    NEW YORK (Reuters Health)—Effective pharmacotherapy of rheumatoid arthritis (RA) is not associated with meaningful improvements in mental health, according to a systematic review and meta-analysis. “We were surprised by the small effect sizes for mental-health outcomes across all of the treatments included in this review, but particularly for the anti-TNF versus disease-modifying antirheumatic drug (DMARD)…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences